12 Best Fundamentally Strong Penny Stocks to Buy Right Now

Page 9 of 10

2. Jaguar Health, Inc. (NASDAQ:JAGX)

Upside Potential as of September 19, 2025: 1405.38%

On September 9, 2025, Jaguar Health, Inc. (NASDAQ:JAGX) signed securities purchase agreements with some investors for the issuance and sale of nearly 951 shares of Series N Perpetual Preferred Stock. The funds from this $2.38 million private placement transaction will be allocated to working capital, general corporate purposes, and repayment of certain existing notes.

The year 2025 marked a pivotal year of convergence for Jaguar Health, Inc. (NASDAQ:JAGX). During its latest earnings call, management highlighted an intersection of clinical and regulatory catalysts that could prove transformative for the company. With a clear strategy to pursue business development partnerships for licensed rights, the company is committed to achieving the impossible.

What’s even more interesting is that Jaguar Health, Inc. (NASDAQ:JAGX) is now enhancing its product portfolio by supporting investigator-initiated trials in adult patients living with short bowel syndrome and intestinal failure. While patient treatment has already begun, results aren’t expected until 2026.

Jaguar Health, Inc. (NASDAQ:JAGX), headquartered in San Francisco, California, is a commercial-stage pharmaceuticals company specializing in plant-based prescription medicines for people and animals suffering from gastrointestinal distress. The company operates through two segments: Animal Health and Human Health.

Page 9 of 10